Drug combinations for malaria: time to ACT?

dc.contributor.author	Mutabingwa, Theonest K.
dc.date.accessioned	2020-10-08T07:02:17Z
dc.date.available	2020-10-08T07:02:17Z
dc.date.issued	2004
dc.description.abstract	The scientist and popular writer Robert Desowitz calls malaria 'the oldest emerging disease'. Malaria is certainly old: the written records of the earliest human civilizations describe the distinct periodic fevers. From the vantage point of populations suffering under the burden of malaria, the thought that malaria might also be emerging or re-emerging is frightening but accurate. Despite its already enormous toll of human suffering, deaths due to malaria are increasing. A major factor contributing to the resurgence of malaria is drug resistance. For 50 years after its discovery, chloroquine was a cheap, safe, and effective oral drug for malaria in Africa. In many parts of Africa, chloroquine is no longer effective because of chloroquine-resistant parasites that are spreading rapidly throughout the remainder of the continent.	en_US
dc.identifier.citation	Duffy, P.E. and Mutabingwa, T.K., 2004. Drug combinations for malaria: time to ACT?. The Lancet, 363(9402), pp.3-3.	en_US
dc.identifier.other	DOI: 10.1016/S0140-6736(03)15230-
dc.identifier.uri	http://hdl.handle.net/123456789/618
dc.language.iso	en	en_US
dc.publisher	The Lancet	en_US
dc.subject	Malaria	en_US
dc.subject	Parasite	en_US
dc.subject	Prescription drugs	en_US
dc.title	Drug combinations for malaria: time to ACT?	en_US
dc.type	Article	en_US